CD4 and pancreatic neoplasm: In a study of patients undergoing RFA for locally advanced pancreatic cancer, Giardino and colleagues showed that CD4+, CD8+ and effector memory T cells increased from day 3 and myeloid antigen presenting dendritic cells increased at day 30, suggesting activation of the adaptive response.